Skip to main content

Day: December 16, 2025

Resolutions of Baltic Horizon Fund repeat extraordinary general meeting

A repeat extraordinary General Meeting (hereinafter the “General Meeting”) of Baltic Horizon Fund unit-holders took place on 16 December 2025 in Tallinn, Estonia.   The repeat meeting was convened as the required quorum was not reached during the initial extraordinary General Meeting on 8 December 2025. In accordance with section 10.11 of the fund rules of Baltic Horizon Fund the repeat General Meeting is permitted to adopt resolutions regardless of the number of votes represented at the meeting, unless otherwise stipulated in the fund rules. A total of 58,923,830 Baltic Horizon Fund units were represented at the meeting, which account for 41.05% of the total number of votes in the fund. The agenda of the meeting was to decide on the issuance of new units during Q1 2026 in order to strengthen the balance sheet of Baltic Horizon Fund. The...

Continue reading

Golden Triangle Ventures Signs LOI to Lease Canning & Manufacturing Facility to Establish Central Hub for Brand Creation and Product Development

AUSTIN, Texas, Dec. 16, 2025 (GLOBE NEWSWIRE) — via IBN — Golden Triangle Ventures, Inc. (OTC: GTVH) announces it has signed a Letter of Intent (LOI) to lease a canning and manufacturing facility that will serve as the company’s central hub for beverage production, brand development, and private-label services. The planned facility will support GTVH’s strategy to build a streamlined platform where new and existing brands can be developed, produced, and prepared for market under one operation. A Practical, Full-Service Brand Development Center The facility is intended to house core functions including:Canning and beverage manufacturing Product formulation and development White-label and private-label production Brand creation and marketing support Joint-venture opportunities with public figures, influencers, and partnersBy...

Continue reading

Akari Therapeutics Announces $5 Million Financing, Including Concurrent Registered Direct Offering and Private Placement Priced At-Market

New cash portion of offering includes >20% participation from Directors, Officers and Executive Management TAMPA, Fla. and LONDON, Dec. 16, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX) (the “Company”), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 12,607,487 of the Company’s American Depositary Shares (“ADSs”) or ADS equivalents in lieu thereof, each representing 2,000 ordinary shares. In addition, the Company has agreed to issue unregistered warrants to purchase an aggregate of 12,607,487 ADSs. The offering included significant participation from Directors, Officers and Executive Management along with certain institutional investors, and was priced at-the-market...

Continue reading

Freight Technologies Announces Deal to Acquire JAK Solar

Broadens Asset Base | Enhances Financial Flexibility | Adds Recurring Cash Flows HOUSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) — Freight Technologies, Inc. (Nasdaq: FRGT, “Fr8Tech” or the “Company”), a logistics management innovation company offering a diverse portfolio of technology-driven solutions, announced that it has entered into a share purchase agreement to acquire JAK Solar Loans 1 Limited (“JAK Solar”). JAK Solar operates a scalable platform focused on the ownership and servicing of residential solar-related financial contracts, supported by established servicing arrangements and predictable payment structures. As of November 30, 2025, JAK Solar owned a portfolio of 62 active and performing U.S.-based residential solar loans with aggregate outstanding principal and interest through maturity of approximately $1.85 million and...

Continue reading

Cyderes Acquires Lucidum to Develop Identity-Centric Security Data Fabric for Modern Cyber Defense

Acquisition unifies Cyderes’ Identity Access Management (IAM), Exposure Management, Managed Detection & Response (MDR) solutions, accelerating agentic AI capabilities KANSAS CITY, Mo., Dec. 16, 2025 (GLOBE NEWSWIRE) — Cyderes, a global managed cybersecurity services partner focused on defending against today’s most sophisticated threats, announced the acquisition of Lucidum, a leading provider of security data fabric and entity intelligence. The acquisition provides Cyderes with a unified, identity-aware foundation, strengthening its core solutions while setting the stage for greater output across existing agentic AI offerings and supporting the development of advanced AI-driven remediation workflows for clients. Many organizations continue to operate with fragmented, inconsistent data across identity systems, assets, entitlements,...

Continue reading

Dime Awards Grant to Accompany Capital

HAUPPAUGE, N.Y., Dec. 16, 2025 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced that Dime has awarded a grant to Accompany Capital in support of their mission to help underserved entrepreneurs succeed by empowering them to create jobs, stimulate economic growth, and boost New York City communities. ABOUT DIME COMMUNITY BANCSHARES, INC. Dime Community Bancshares, Inc. is the holding company for Dime Community Bank, a New York State-chartered trust company with over $14 billion in assets and the number one deposit market share among community banks on Greater Long Island (1). Dime Community Bancshares, Inc.Investor Relations Contact:Avinash ReddySenior Executive Vice President – Chief Operating Officer and Chief Financial...

Continue reading

Can-Fite Provides Update on Clinical and Financial Status

RAMAT GAN, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced an update on its clinical development activities and financial status. Namodenoson drug candidate: Can-Fite is currently enrolling patients in a pivotal Phase III clinical study evaluating Namodenoson for the treatment of advanced hepatocellular carcinoma (HCC) in patients with Child-Pugh B7 liver function. This patient population represents a significant unmet medical need, as no approved therapies are currently available. An interim analysis from the Phase III study is expected to be in approximately Q4 2026. Subject to positive interim results, the Company may be eligible...

Continue reading

INVL Baltic Farmland investor’s calendar for 2026

INVL Baltic Farmland plans to publish information to investors in 2026 in accordance with the following calendar: 27 February – 1 March 2026 – audited financial reports and annual management report;19 May 2026 – preliminary operating results and factsheet for 3 months of 2026;18 August 2026 – semi-annual management report of 2026;17 November 2026 – preliminary operating results and factsheet for 9 months of 2026. The person authorized to provide additional information:Director Egle SurplieneE-mail: egle.surpliene@invaldainvl.com

Continue reading

Cycurion Debuts on MSSP Alert’s 2025 Top 250 MSSPs List, Ranking No. 116 and Earning Top-Tier Industry Recognition

MCLEAN, Va., Dec. 16, 2025 (GLOBE NEWSWIRE) — Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity and AI-driven solutions, today announced its selection to the 2025 MSSP 250 ranking. The Company now stands among the world’s top leading managed security services providers, according to MSSP Alert, a CyberRisk Alliance resource. Cycurion earned a placement in the top 50%, debuting at No. 116. This marks the Company’s first year being evaluated for this prestigious ranking of global cybersecurity leaders. The annual MSSP 250 ranking assesses organizations on a range of performance and industry criteria, including:Annual recurring revenue Profitability Business growth rate Cybersecurity professional headcount Breadth and maturity of managed security services MSSP Alert’s editorial assessment...

Continue reading

Rocky Shore Identifies Higher Gold Grades Within Recently Acquired Gold Deposits at its Gold Anchor Project in Newfoundland

TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) — Rocky Shore Gold Ltd. (“Rocky Shore” or the “Company”) (CSE: RSG) is pleased to announce that ongoing data compilation at its recently optioned Mosquito Hill and recently acquired Reid gold deposits (see news releases dated December 12, 2025 and December 2, 2025) has identified thick, higher-grade gold intervals within both deposits’ mineralized envelopes from historical drill logs. Both porphyry-controlled gold deposits are at surface and are open along strike and at depth and adjoin the Company’s 100% owned Gold Anchor Project. They are strategically adjacent to Rocky Shore’s 11-kilometre-long Lane Pond Gold Target; a structurally-controlled high-grade gold target associated with the prolific Appleton Fault Corridor. The Gold Anchor Project is located within an emerging gold district...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.